Astrana Health Inc (ASTH): A Comprehensive StockValueFinder Review
Astrana Health Inc is a healthcare company operating in the medical care facilities industry. This review aims to provide an educational analysis of ASTH's performance based on StockValueFinder metrics, focusing on financial health and valuation.
#### Why the StockValueFinder Score Matters StockValueFinder evaluates companies across multiple financial health indicators to determine an overall score that reflects their attractiveness as investment candidates. For Astrana Health Inc (ASTH), the current score is 17%, which falls into the "AVOID" category, indicating significant risks or weaknesses in its fundamentals.
#### EPS Strength and Consistency Earnings Per Share (EPS) consistency is a critical metric for evaluating a company's financial health and growth potential. A stable and increasing EPS over time suggests that the company can generate consistent profits and invest in future opportunities effectively.
– **Supplied Fact:** Did not pass – **Explanation:** StockValueFinder requires companies to demonstrate strong earnings stability, typically through several years of positive EPS growth. Without detailed historical data on EPS trends for ASTH, we cannot determine specific values or patterns. However, the system flagged ASTH as failing this test, suggesting potential issues with earnings reliability.
#### ROIC and Capital Efficiency Return On Invested Capital (ROIC) measures how efficiently a company uses its capital to generate profits. A higher ROIC indicates better use of resources and stronger competitive positioning.
– **Supplied Fact:** 1.21% – **Strong Range:** Preferably above 10% – **Weak Range:** Below 5% – **Explanation:** ASTH's ROIC is at a low 1.21%, which falls well below the preferred range of 10% or higher. This suggests that the company may be struggling to generate sufficient returns on its capital investments, indicating inefficient use of resources and potentially weaker competitive standing.
#### Interest Coverage and Financial Safety Interest coverage ratio measures a company's ability to meet interest obligations with earnings before interest and taxes (EBIT). A higher ratio indicates stronger financial stability.
– **Supplied Fact:** Did not pass – **Strong Range:** 6 or higher – **Weak Range:** Below 3 – **Explanation:** The system flagged ASTH as failing the interest coverage test, indicating that its ability to cover interest expenses may be insufficient. This suggests potential risks related to debt servicing and financial stability.
#### Debt Payback and Balance Sheet Discipline Debt payback period reflects how long it would take a company to repay all of its outstanding debt using current earnings before interest and taxes (EBIT). A shorter period indicates better balance sheet health.
– **Supplied Fact:** 9.48 years – **Strong Range:** 3 years or less – **Weak Range:** More than 5 years – **Explanation:** ASTH's debt payback period of 9.48 years is significantly longer than the preferred range, indicating that it would take a considerable amount of time to repay its debts. This suggests potential liquidity and solvency risks.
#### P/E Ratio and Valuation Discipline The Price-to-Earnings (P/E) ratio measures how much investors are willing to pay for each dollar of earnings. A lower P/E typically indicates better value, assuming the company's fundamentals are sound.
– **Supplied Fact:** 45.67 – **Strong Range:** Below 15 – **Weak Range:** Above 30 – **Explanation:** ASTH has a high P/E ratio of 45.67, which is well above the preferred range of 15 or lower. This suggests that the stock may be overvalued relative to its earnings performance.
#### Moving Average Trend and Entry Timing The moving average trend signal provides insights into the current market sentiment towards the stock based on price movements over time. However, it should not be viewed as a guarantee of future returns but rather as an indicator for timing discipline.
– **Supplied Fact:** STRONG BUY TREND – **Entry Signal:** N/A – **Explanation:** While StockValueFinder indicates a strong buy trend, the entry signal is not provided, meaning there are no specific price levels recommended for buying or selling. This suggests that while market sentiment may be positive, investors should still exercise caution due to the company's underlying financial weaknesses.
#### Overall Financial Strengths and Weaknesses **Strengths:** – **Moving Average Trend:** Positive trend signal indicating potential short-term momentum.
**Weaknesses:** – **EPS Consistency:** Lack of consistent earnings growth or stability. – **ROIC Efficiency:** Poor capital efficiency with a low ROIC. – **Interest Coverage:** Insufficient ability to cover interest expenses. – **Debt Payback Period:** Long period needed to repay debt, indicating liquidity risks. – **P/E Ratio:** High valuation relative to earnings.
#### Risks and Limitations Investing in ASTH carries significant financial risks due to its poor EPS consistency, low ROIC, insufficient interest coverage, lengthy debt payback period, and high P/E ratio. These factors collectively suggest that the company may struggle with capital efficiency, liquidity management, and market valuation, posing substantial challenges for investors.
#### Educational Conclusion This review of Astrana Health Inc (ASTH) highlights the importance of evaluating multiple financial metrics to assess a stock's overall attractiveness and risk profile. By understanding EPS consistency, ROIC, interest coverage, debt payback period, P/E ratio, and moving average trends, investors can make more informed decisions about potential investments.
This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.
Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings
Specializing in monetary economics, market incentives, and investment risk.